These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 9759679)

  • 1. Clinical approach to scleroderma.
    White B
    Semin Cutan Med Surg; 1998 Sep; 17(3):213-8. PubMed ID: 9759679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Digital ulcers and cutaneous subsets of systemic sclerosis: Clinical, immunological, nailfold capillaroscopy, and survival differences in the Spanish RESCLE Registry.
    Tolosa-Vilella C; Morera-Morales ML; Simeón-Aznar CP; Marí-Alfonso B; Colunga-Arguelles D; Callejas Rubio JL; Rubio-Rivas M; Freire-Dapena M; Guillén-Del Castillo A; Iniesta-Arandia N; Castillo-Palma MJ; Egurbide-Arberas M; Trapiellla-Martínez L; Vargas-Hitos JA; Todolí-Parra JA; Rodriguez-Carballeira M; Marin-Ballvé A; Pla-Salas X; Rios-Blanco JJ; Fonollosa-Pla V;
    Semin Arthritis Rheum; 2016 Oct; 46(2):200-208. PubMed ID: 27312381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and evolution of scleroderma pattern at nailfold videocapillaroscopy in systemic sclerosis patients: Clinical and prognostic implications.
    Ghizzoni C; Sebastiani M; Manfredi A; Campomori F; Colaci M; Giuggioli D; Ferri C
    Microvasc Res; 2015 May; 99():92-5. PubMed ID: 25842153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidences and Risk Factors of Organ Manifestations in the Early Course of Systemic Sclerosis: A Longitudinal EUSTAR Study.
    Jaeger VK; Wirz EG; Allanore Y; Rossbach P; Riemekasten G; Hachulla E; Distler O; Airò P; Carreira PE; Balbir Gurman A; Tikly M; Vettori S; Damjanov N; Müller-Ladner U; Distler JH; Li M; Walker UA;
    PLoS One; 2016; 11(10):e0163894. PubMed ID: 27706206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First clinical symptom as a prognostic factor in systemic sclerosis: results of a retrospective nationwide cohort study.
    Rubio-Rivas M; Corbella X; Pestaña-Fernández M; Tolosa-Vilella C; Guillen-Del Castillo A; Colunga-Argüelles D; Trapiella-Martínez L; Iniesta-Arandia N; Castillo-Palma MJ; Sáez-Comet L; Egurbide-Arberas MV; Ortego-Centeno N; Freire M; Vargas-Hitos JA; Ríos-Blanco JJ; Todolí-Parra JA; Rodríguez-Carballeira M; Marín-Ballvé A; Segovia-Alonso P; Pla-Salas X; Madroñero-Vuelta AB; Ruiz-Muñoz M; Fonollosa-Pla V; Simeón-Aznar CP; ; Callejas Moraga E; Calvo E; Carbonell C; Castillo MJ; Chamorro AJ; Colunga D; Corbella X; Egurbide MV; Espinosa G; Fonollosa V; Freire M; García Hernández FJ; González León R; Guillén Del Castillo A; Iniesta N; Lorenzo R; Madroñero AB; Marí B; Marín A; Ortego-Centeno N; Pérez Conesa M; Pestaña M; Pla X; Ríos Blanco JJ; Rodríguez Carballeira M; Rubio Rivas M; Ruiz Muñoz M; Sáez Comet L; Segovia P; Simeón CP; Soto A; Tarí E; Todolí JA; Tolosa C; Trapiella L; Vargas Hitos JA; Verdejo G
    Clin Rheumatol; 2018 Apr; 37(4):999-1009. PubMed ID: 29214548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic sclerosis. A clinical overview.
    Generini S; Fiori G; Moggi Pignone A; Matucci Cerinic M; Cagnoni M
    Adv Exp Med Biol; 1999; 455():73-83. PubMed ID: 10599326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current and Future Outlook on Disease Modification and Defining Low Disease Activity in Systemic Sclerosis.
    Nagaraja V; Matucci-Cerinic M; Furst DE; Kuwana M; Allanore Y; Denton CP; Raghu G; Mclaughlin V; Rao PS; Seibold JR; Pauling JD; Whitfield ML; Khanna D
    Arthritis Rheumatol; 2020 Jul; 72(7):1049-1058. PubMed ID: 32134199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations with digital ulcers in a large cohort of systemic sclerosis: results from the Canadian Scleroderma Research Group registry.
    Khimdas S; Harding S; Bonner A; Zummer B; Baron M; Pope J;
    Arthritis Care Res (Hoboken); 2011 Jan; 63(1):142-9. PubMed ID: 20740608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Digital ulcers predict a worse disease course in patients with systemic sclerosis.
    Mihai C; Landewé R; van der Heijde D; Walker UA; Constantin PI; Gherghe AM; Ionescu R; Rednic S; Allanore Y; Avouac J; Czirják L; Hachulla E; Riemekasten G; Cozzi F; Airò P; Cutolo M; Mueller-Ladner U; Matucci-Cerinic M;
    Ann Rheum Dis; 2016 Apr; 75(4):681-6. PubMed ID: 25688073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical manifestations of systemic sclerosis.
    Steen VD
    Semin Cutan Med Surg; 1998 Mar; 17(1):48-54. PubMed ID: 9512107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of morbidity and mortality of systemic sclerosis in Canada.
    Al-Dhaher FF; Pope JE; Ouimet JM
    Semin Arthritis Rheum; 2010 Feb; 39(4):269-77. PubMed ID: 18706680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic dyspnea with Raynaud's phenomenon and elevated ANA: A diagnosis of systemic sclerosis sine scleroderma.
    Chong WH; Saha BK; Beegle S
    Am J Med Sci; 2023 Feb; 365(2):198-204. PubMed ID: 35276077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early systemic sclerosis: assessment of clinical and pre-clinical organ involvement in patients with different disease features.
    Valentini G; Cuomo G; Abignano G; Petrillo A; Vettori S; Capasso A; Cozzolino D; Del Genio G; Santoriello C
    Rheumatology (Oxford); 2011 Feb; 50(2):317-23. PubMed ID: 20562195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe organ involvement in systemic sclerosis with diffuse scleroderma.
    Steen VD; Medsger TA
    Arthritis Rheum; 2000 Nov; 43(11):2437-44. PubMed ID: 11083266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival prognostic factors and markers of morbidity in Spanish patients with systemic sclerosis.
    Simeon CP; Armadans L; Fonollosa V; Vilardell M; Candell J; Tolosa C; Mearin F; Rodrigo MJ; Solans R; Lima J; Sampol G
    Ann Rheum Dis; 1997 Dec; 56(12):723-8. PubMed ID: 9496151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic sclerosis/scleroderma: a treatable multisystem disease.
    Hinchcliff M; Varga J
    Am Fam Physician; 2008 Oct; 78(8):961-8. PubMed ID: 18953973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Systemic sclerosis].
    Legendre P; Mouthon L
    Rev Prat; 2017 Sep; 67(7):775-783. PubMed ID: 30512777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interrelationships between pulmonary and extrapulmonary involvement in systemic sclerosis. A longitudinal analysis.
    Tashkin DP; Clements PJ; Wright RS; Gong H; Simmons MS; Lachenbruch PA; Furst DE
    Chest; 1994 Feb; 105(2):489-95. PubMed ID: 8306752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon.
    Merkel PA; Herlyn K; Martin RW; Anderson JJ; Mayes MD; Bell P; Korn JH; Simms RW; Csuka ME; Medsger TA; Rothfield NF; Ellman MH; Collier DH; Weinstein A; Furst DE; Jiménez SA; White B; Seibold JR; Wigley FM;
    Arthritis Rheum; 2002 Sep; 46(9):2410-20. PubMed ID: 12355489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR).
    Kowal-Bielecka O; Landewé R; Avouac J; Chwiesko S; Miniati I; Czirjak L; Clements P; Denton C; Farge D; Fligelstone K; Földvari I; Furst DE; Müller-Ladner U; Seibold J; Silver RM; Takehara K; Toth BG; Tyndall A; Valentini G; van den Hoogen F; Wigley F; Zulian F; Matucci-Cerinic M;
    Ann Rheum Dis; 2009 May; 68(5):620-8. PubMed ID: 19147617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.